The summary of product characteristics (SmPC) for the antiepileptic medicine Keppra (levetiracetam; UCB Pharma) has been updated to include clinical trials that did not suggest an increased risk of autism or intellectual disability in children…
Levetiracetam information updated to include studies that suggest no link to autism
